bromodeoxyuridine has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beecken, WD; Joussen, AM; Kirchhof, B; Moromizato, Y; Poulaki, V; Schwartz, A | 1 |
Asakai, R; Kudo, H; Mori, T; Sakamoto, S; Sassa, S; Zhou, YF | 1 |
2 other study(ies) available for bromodeoxyuridine and o-(chloroacetylcarbamoyl)fumagillol
Article | Year |
---|---|
Inhibition of inflammatory corneal angiogenesis by TNP-470.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Bromodeoxyuridine; Cell Division; Corneal Neovascularization; Cyclohexanes; DNA Replication; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Corneal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Injections, Subcutaneous; Lymphokines; Mice; Mice, Inbred C57BL; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice.
Topics: Adenomyoma; Angiogenesis Inhibitors; Animals; Body Weight; Bromodeoxyuridine; Cyclohexanes; Estrous Cycle; Female; Immunohistochemistry; Mice; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Organ Size; Random Allocation; Sesquiterpenes; Thymidine Kinase; Thymidylate Synthase; Uterine Neoplasms | 2003 |